(Q24241001)

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Sulthiame in the primary therapy of West syndrome: a randomized double-blind placebo-controlled add-on trial on baseline pyridoxine medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Short term effects of valproate on infantile spasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Randomized trial of vigabatrin in patients with infantile spasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Double-blind study of ACTH vs prednisone therapy in infantile spasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

A comparative study of high-dose and low-dose ACTH therapy for West syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

The efficacy and side effects of topiramate on refractory epilepsy in infants and young children: a multi-center clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Topiramate slow dose titration: improved efficacy and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Topiramate in long-term treatment of epilepsy in the intellectually disabled

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Use of ACTH and prednisolone in infantile spasms: experience from a developing country

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Behavioural effects of the newer antiepileptic drugs: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Behavioural and neuropsychological problems in refractory paediatric epilepsies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Combined treatment with vigabatrin and topiramate in West syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Nitrazepam for refractory infantile spasms and the Lennox-Gastaut syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Add-on treatment with pyridoxine and sulthiame in 12 infants with West syndrome: an open clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

The promise of new antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Treatment of hypsarrhythmia and infantile spasms with a librium analogue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Zonisamide in pediatric epilepsy: review of the Japanese experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Computed tomography in infantile spasms: effects of hormonal therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Efficacy and safety of topiramate in infants according to epilepsy syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

A Controlled Study of Prednisone Therapy in Infantile Spasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Clinical study of oral administration of DN-1417, a TRH analog, in patients with intractable epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Clinical study of catastrophic infantile epilepsy with focal seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

The effects of ACTH and corticosteroids on epileptiform disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Optimizing the indication of vigabatrin in children with refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Zonisamide treatment for symptomatic infantile spasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Clinical effects of thyrotropin-releasing hormone for severe epilepsy in childhood: a comparative study with ACTH therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Topiramate: efficacy and tolerability in children according to epilepsy syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Efficacy, tolerability, and kinetics of lamotrigine in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Clinical pharmacology and therapeutic drug monitoring of zonisamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Meta-analysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Epileptic encephalopathies: a brief overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Extremely low-dose ACTH step-up protocol for West syndrome: maximum therapeutic effect with minimal side effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Zonisamide in the management of epilepsy--Japanese experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

A study of spike-density on EEG in West syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Treatment of infantile spasms with high-dosage vitamin B6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Uncoupling of EEG-clinical neonatal seizures after antiepileptic drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Long-term response to zonisamide in patients with West syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Clinical effects of allopurinol on intractable epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Management issues in severe childhood epilepsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Vigabatrin as a first-line drug in West syndrome: clinical and electroencephalographic outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Overview of Japanese experience-controlled and uncontrolled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Liposteroid (dexamethasone palmitate) therapy for West syndrome: a comparative study with ACTH therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Efficacy of zonisamide: our experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Adrenocorticotropic hormone and vigabatrin treatment of children with infantile spasms underlying cerebral palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

The epidemiology and natural history of infantile spasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

A proposal for case definitions and outcome measures in studies of infantile spasms and West syndrome: consensus statement of the West Delphi group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Long-term otucome of West syndrome: a study of adults with a history of infantile spasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

Use of Valproic Acid in Treatment of Infantile Spasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

7 January 2021

Infantile spasms. Comparative trial of nitrazepam and corticotropin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

7 January 2021

High-dose, long-duration versus low-dose, short-duration corticotropin therapy for infantile spasms

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

7 January 2021

Therapy of infantile spasms

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

7 January 2021

Lamotrigine in infantile spasms

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

7 January 2021

Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

7 January 2021

Lamotrigine--an update

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

7 January 2021

Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

7 January 2021

High dose B6 treatment in infantile spasms

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

7 January 2021

A Double-blind Study of Clonazepam in the Treatment of Therapy-resistant Epilepsy in Children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

7 January 2021

Treatment of infantile spasms and Lennox-Gastaut syndrome with clonazepam (Rivotril)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

7 January 2021

A Prospective Study of Infantile Spasms: Clinical and Therapeutic Correlations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

7 January 2021

Controlled and comparative trials with valproate: United States

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

7 January 2021

Vigabatrin in the treatment of childhood epilepsies: a single-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

7 January 2021

Treatment of infantile spasms with methysergide and alpha-methylparatyrosine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

7 January 2021

Lamotrigine in treatment of 120 children with epilepsy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

1 reference

7 January 2021

Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

7 January 2021

Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

7 January 2021

Intravenous immunoglobulin as adjunctive therapy for juvenile spasms

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

7 January 2021

Topiramate for the treatment of infantile spasms

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

7 January 2021

The treatment of infantile spasms by child neurologists

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

1 reference

7 January 2021

Treatment of infantile spasms

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001770.PUB2

7 January 2021